Diagnos, Inc.

  • Market Cap: N/A
  • Industry: Computers - Software & Consulting
  • ISIN: CA2524423068
CAD
0.29
-0.07 (-20.31%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

136.5 k

Shareholding (Mar 2020)

FII

0.46%

Held by 2 FIIs

DII

99.54%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Computers - Software & Consulting

stock-summary
Market cap

CAD 34 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.98

stock-summary
Return on Equity

314.84%

stock-summary
Price to Book

-21.87

Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Jun 2025)
Net Profit:
-1 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
163.64%
0%
163.64%
6 Months
118.05%
0%
118.05%
1 Year
197.44%
0%
197.44%
2 Years
-12.91%
0%
-12.91%
3 Years
-74.78%
0%
-74.78%
4 Years
20.83%
0%
20.83%
5 Years
14.62%
0%
14.62%

Diagnos, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-4.85%
EBIT Growth (5y)
-18.56%
EBIT to Interest (avg)
-2.72
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.25
Sales to Capital Employed (avg)
0.11
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.46%
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-37.91
EV to EBIT
-9.06
EV to EBITDA
-9.34
EV to Capital Employed
-38.69
EV to Sales
38.69
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2020stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 2 Foreign Institutions (0.46%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 15.38% vs -8.33% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.00",
          "val2": "-1.30",
          "chgp": "23.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.20",
          "chgp": "-50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.10",
          "val2": "-1.30",
          "chgp": "15.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-53,390.90%",
          "val2": "-70,001.70%",
          "chgp": "1,661.08%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is -50.00% vs -60.00% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -38.71% vs -24.00% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.10",
          "val2": "0.20",
          "chgp": "-50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-3.70",
          "val2": "-2.60",
          "chgp": "-42.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.60",
          "val2": "0.60",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-4.30",
          "val2": "-3.10",
          "chgp": "-38.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-36,748.20%",
          "val2": "-15,780.00%",
          "chgp": "-2,096.82%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary

Jun'25
Mar'25
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-1.00
-1.30
23.08%
Interest
0.10
0.20
-50.00%
Exceptional Items
0.00
0.10
-100.00%
Consolidate Net Profit
-1.10
-1.30
15.38%
Operating Profit Margin (Excl OI)
-53,390.90%
-70,001.70%
1,661.08%
USD in Million.
Net Sales

QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 15.38% vs -8.33% in Mar 2025

Annual Results Snapshot (Consolidated) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
0.10
0.20
-50.00%
Operating Profit (PBDIT) excl Other Income
-3.70
-2.60
-42.31%
Interest
0.60
0.60
Exceptional Items
0.10
0.00
Consolidate Net Profit
-4.30
-3.10
-38.71%
Operating Profit Margin (Excl OI)
-36,748.20%
-15,780.00%
-2,096.82%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is -50.00% vs -60.00% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is -38.71% vs -24.00% in Mar 2024

stock-summaryCompany CV
About Diagnos, Inc. stock-summary
stock-summary
Diagnos, Inc.
Computers - Software & Consulting
DIAGNOS Inc. provides data mining and interpretation consulting services, and designs data analytics software products. The Company operates through two segments: Healthcare and Natural resources. Its Healthcare segment offers image analysis services through Computer Assisted Retinal Analysis (CARA), a software tool, which assists health specialists in the detection of diabetic retinopathy. CARA is a hosted Web-based application that integrates fundus cameras with an image processing engine over an Internet connection. Its Natural resources segment offers data mining consulting services through Computer Aided Resource Detection System (CARDS), a software tool used to assist exploration companies in identifying mining deposits. In addition, it offers project management services. The Company operates in Canada, the United Arab Emirates, India, Mexico, Switzerland, the United States, Poland and Colombia.
Company Coordinates stock-summary
Company Details
7005 Taschereau Blvd Suite 340 , BROSSARD QC : J4Z 1A7
stock-summary
Tel: 1 450 6788882
stock-summary
Registrar Details